---
title: 'Laboratory and Metabolomic Fingerprint in Heart Failure with Preserved Ejection
  Fraction: From Clinical Classification to Biomarker Signature'
date: '2023-01-21'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/36671558/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1Zkrxt7ktlCbHBXEV3v65xxSnkSWNsJ1A6Fq3gBniKhGfIUslK&fc=20210907212339&ff=20230124200914&v=2.17.9.post6+86293ac
source: metablomics[MeSH Terms]
description: Heart failure with preserved ejection fraction (HFpEF) remains a poorly
  characterized syndrome with many unknown aspects related to different patient profiles,
  various associated risk factors and a wide range of aetiologies. It comprises several
  pathophysiological pathways, such as endothelial dysfunction, myocardial fibrosis,
  extracellular matrix deposition and intense inflammatory system activation. Until
  now, HFpEF has only been described with regard to clinical features and its most
  ...
---
Heart failure with preserved ejection fraction (HFpEF) remains a poorly characterized syndrome with many unknown aspects related to different patient profiles, various associated risk factors and a wide range of aetiologies. It comprises several pathophysiological pathways, such as endothelial dysfunction, myocardial fibrosis, extracellular matrix deposition and intense inflammatory system activation. Until now, HFpEF has only been described with regard to clinical features and its most ...